Simple and validated UHPLC method coupled to UV detection for determination of daptomycin in human plasma and urine

Biomedical Chromatography

Volumn 28, Issue 3, 2014, Pages 317-319

  Naito, Takafumi ^a   Yamada, Takahiro ^a   Yagi, Tatsuya ^a   Kawakami, Junichi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Daptomycin; Human; Plasma; UHPLC; Urine

Indexed keywords

BACTERIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PLASMA (HUMAN); PRECIPITATION (CHEMICAL);

DAPTOMYCIN; GRAM-POSITIVE BACTERIUM; HUMAN; HUMAN PLASMAS; HUMAN URINE; LIPOPEPTIDES; SIMPLE++; UHPLC; URINE; UV DETECTION;

PARTICLE SIZE;

DAPTOMYCIN;

AREA UNDER THE CURVE; ARTICLE; CASE REPORT; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; DRUG URINE LEVEL; HUMAN; KIDNEY CLEARANCE; MAXIMUM PLASMA CONCENTRATION; PARTICLE SIZE; PRECIPITATION; SUPERNATANT; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET RADIATION; URINARY EXCRETION; VALIDATION PROCESS;

POSIBACTERIA;

DAPTOMYCIN; HUMAN; PLASMA; UHPLC; URINE;

ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DAPTOMYCIN; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84893728584     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.3023     Document Type: Article

References (10)

1. Bazoti FN, Gikas E, Skoutelis A and Tsarbopoulos A. Development and validation of an ultra performance liquid chromatography-tandem mass spectrometry method for the quantification of daptomycin in human plasma. Journal of Pharmaceutical and Biomedical Analysis 2011; 56: 78-85.
2. Dvorchik BH, Brazier D, DeBruin MF and Arbeit RD. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrobial Agents and Chemotherapy 2003; 47: 1318-1323.
3. Dvorchik B, Arbeit RD, Chung J, Liu S, Knebel W and Kastrissios H. Population pharmacokinetics of daptomycin. Antimicrobial Agents and Chemotherapy 2004; 48: 2799-2807.
4. Gika HG, Michopoulos F, Divanis D, Metalidis S, Nikolaidis P and Theodoridis GA. Daptomycin determination by liquid chromatography-mass spectrometry in peritoneal fluid, blood plasma, and urine of clinical patients receiving peritoneal dialysis treatment. Analytical and Bioanalytical Chemistry 2010; 397: 2191-2197.
5. Gikas E, Bazoti FN, Fanourgiakis P, Perivolioti E, Roussidis A, Skoutelis A and Tsarbopoulos A. Development and validation of a UPLC-UV method for the determination of daptomycin in rabbit plasma. Biomedical Chromatography 2010; 24: 522-527.
6. LaPlante KL and Rybak MJ. Daptomycin - a novel antibiotic against Gram-positive pathogens. Expert Opinion on Pharmacotherapy 2004; 5: 2321-2331.
7. Martens-Lobenhoffer J, Kielstein JT, Oye C and Bode-Böger SM. Validated high performance liquid chromatography-UV detection method for the determination of daptomycin in human plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2008; 875: 546-550.
8. Tobin CM, Darville JM, Lovering AM and Macgowan AP. An HPLC assay for daptomycin in serum. Journal of Antimicrobial Chemotherapy 2008; 62: 1462-1463.
9. US Food and Drug Administration. 2001. Guidance for Industry: Bioanalytical Method Validation. Available at: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf#search='Guidance for Industry Bioanalytical Method Validation (accessed 9 July 2013).
10. Verdier MC, Bentué-Ferrer D, Tribut O, Collet N, Revest M and Bellissant E. Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application. Clinical Chemistry and Laboratory Medicine 2011; 49: 69-75.